Tumor localization of 16beta-18-F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer. - Larson,S.M.; Morris,M.; Gunther,I.; Beattie,B.; Humm,J.L.; Akhurst,T.A.; Finn,R.D.; Erdi,Y.; Pentlow,K.; Dyke,J.; Squire,O.; Bornmann,W.; et al. (J Nucl Med, 2004)